Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus

NCT05424432 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Esophageal Carcinoma

Interventions

DRUG: Neoadjuvant Chemotherapy
DRUG: Neoadjuvant Toripalimab
RADIATION: Short Course Neoadjuvant Radiotherapy

Sponsor

Jiangsu Cancer Institute & Hospital